DUSA up on actinic keratosis data

DUSA Pharmaceuticals Inc. (NASDAQ:DUSA) gained $0.37 to $5.75 on Thursday after Levulan Kerastick followed by DUSA's

Read the full 166 word article

How to gain access

Continue reading with a
two-week free trial.